These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12021104)

  • 1. IL-1beta expression in islet cells of the NOD mouse and its spatial relationship to beta cells and inducible nitric oxide synthase.
    Reddy S; Young M
    Ann N Y Acad Sci; 2002 Apr; 958():190-3. PubMed ID: 12021104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.
    Reddy S; Young M; Ginn S
    Histochem J; 2001 Jun; 33(6):317-27. PubMed ID: 11758808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
    Reddy S; Yip S; Karanam M; Poole CA; Ross JM
    Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of cyclophosphamide-induced accelerated diabetes in the NOD mouse by nicotinamide or a soy protein-based infant formula.
    Reddy S; Karanam M; Robinson E
    Int J Exp Diabetes Res; 2001; 1(4):299-313. PubMed ID: 11467420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
    Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-label immunohistochemical study of interleukin-4-and interferon-gamma-expressing cells within the pancreas of the NOD mouse during disease acceleration with cyclophosphamide.
    Reddy S; Karanam M; Poole CA; Ross JM
    Autoimmunity; 2000 Oct; 32(3):181-92. PubMed ID: 11092698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Reddy S; Ross JM
    Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of caspase-3 in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ross JM
    Ann N Y Acad Sci; 2003 Nov; 1005():192-5. PubMed ID: 14679058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
    Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration.
    Reddy S; Kaill S; Poole CA; Ross J
    Histochem J; 1997 Jan; 29(1):53-64. PubMed ID: 9088945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.
    Welsh M; Welsh N; Bendtzen K; Mares J; Strandell E; Oberg C; Sandler S
    Diabetologia; 1995 Feb; 38(2):153-60. PubMed ID: 7536171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
    Rothe H; O'Hara RM; Martin S; Kolb H
    Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S; Bai Y; Robinson E; Ross J
    Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
    Flodström M; Eizirik DL
    Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1 beta-induced nitric oxide synthase expression in pancreatic beta cells.
    Akabane A; Kato I; Takasawa S; Unno M; Yonekura H; Yoshimoto T; Okamoto H
    Biochem Biophys Res Commun; 1995 Oct; 215(2):524-30. PubMed ID: 7487987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.